No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Joincare Pharmaceutical Group Industry Co., Ltd. is a Chinese enterprise primarily focused on the comprehensive process of researching, developing, producing, and commercializing pharmaceutical and healthcare products within China. The company boasts a broad pharmaceutical portfolio that includes both Western chemical drug preparations, addressing conditions such as respiratory, gastrointestinal, anti-infection, gonadotropic, and psychiatric disorders, as well as traditional Chinese medicines (TCM), with offerings for anti-tumor and cold relief. Beyond finished drugs, Joincare supplies chemical active pharmaceutical ingredients (APIs) and intermediates. Its operations also extend into the diagnostics sector, where it provides specialized reagents and equipment, such as an autoimmunity multiple detection platform and an IgM diagnostic kit. Furthermore, the company markets a range of health and wellness products, exemplified by American ginseng tea and Jingxin menocare essence. Joincare diversifies its business by engaging in the wholesale and retail of personal care items, including skincare products, cosmetics, and various other essential goods. Its products are available in diverse formats, such as hormone tablets, oral liquid formulations, and standard tablets. Established in 1992, Joincare Pharmaceutical Group maintains its principal offices in Shenzhen, China.
www.joincare.comNo one on the platform currently holds 600380.SS.
No tracked institution reports a position in 600380.SS as of their last filing.
No one on the platform has traded 600380.SS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 46.6% | 62.3% | 102.5% | — | — | — |
| Rev. Growth % | -2.6% | 2.4% | ||||
| Profit Margin % | 8.8% | 8.7% | 9.0% | |||
| Free Cash Flow Margin % | 20.5% | 15.5% | 14.2% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $15.3B | -2.5% | $0.77 | $0.77–$0.77 | — | 1 |
| 2027 | $15.9B | +3.7% | $0.81 | $0.81–$0.81 | — | 1 |
| 2028 | $15.1B | -4.8% | $0.80 | $0.80–$0.80 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 3 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-04-25 | $0.22 | $0.23 | +4.5% |
| 2025-04-24 | $0.22 | $0.15 | -33.2% |
| 2024-10-24 | $0.19 | $0.18 | -5.9% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 600380.SSJoincare Pharmaceutical Group Industry Co.,Ltd. | $9.15 | -0.87% | $16.7B | — |
| 000623.SZJilin Aodong Pharmaceutical Group Co., Ltd. | $17.28 | -0.69% | $20.7B | — |
| 000739.SZApeloa Pharmaceutical Co.,Ltd | $22.76 | +1.74% | $26.4B | — |
| 002262.SZJiangsu Nhwa Pharmaceutical Co., Ltd. | $21.52 | -0.60% | $21.9B | — |
| 300558.SZBetta Pharmaceuticals Co., Ltd. |
| $46.33 |
| +0.26% |
| $19.6B |
| — |
| 300723.SZApicHope Pharmaceutical Co., Ltd | $33.65 | +0.96% | $15.2B | — |
| 600062.SSChina Resources Double-Crane Pharmaceutical Co.,Ltd. | $15.81 | -1.06% | $16.4B | — |
Source: Financial Modeling Prep · peers by sector/industry